Know Cancer

or
forgot password

Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study


N/A
18 Years
N/A
Not Enrolling
Both
Head and Neck Cancer, Head and Neck Cancers

Thank you

Trial Information

Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study


Inclusion Criteria:

1. Patients with malignant tumors seen at the Stanford University
Cancer Center. Eligible patients will have a diagnosis of squamous cell carcinoma (HNSCC)
and will have been seen in the Stanford Head and Neck Oncology Program. A decision to
undergo surgery at Stanford will have been made, prior to recruiting patients for the
study, and prior to obtaining the samples during surgery. (Histological confirmation of
the diagnosis need not be made prior to obtaining consent.) 2. A definitive resection of
a malignant tumor is planned. 3. Surgeon judgment that the definitive procedure will not
be compromised by including

- FNA

- Core needle biopsy

- Cup forceps or punch biopsy of<4mm. 4. Informed consent documented prior to
procedure

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Quantification of the cancer stem cell population by flow cytometry

Outcome Time Frame:

1 month

Safety Issue:

No

Principal Investigator

Dr. A. Dimitrios Colevas

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Food and Drug Administration

Study ID:

ENT0023

NCT ID:

NCT00610415

Start Date:

December 2007

Completion Date:

Related Keywords:

  • Head and Neck Cancer
  • Head and Neck Cancers
  • Head and Neck Neoplasms

Name

Location

Stanford University School of MedicineStanford, California  94305-5317